PHYSIOTENS

This brand name is authorized in Australia, Cyprus, Germany, Estonia, Finland, France, Croatia, Lithuania, Malta, Poland, Romania, Tunisia, Turkey, United Kingdom

Active ingredients

The drug PHYSIOTENS contains one active pharmaceutical ingredient (API):

1 Moxonidine UNII CC6X0L40GW - MOXONIDINE

Moxonidine has been shown to bind selectively to the I1-imidazoline receptors in the brain stem. These imidazoline-sensitive receptors are concentrated in the rostral ventrolateral medulla, an area which is of crucial importance for central control of the peripheral sympathetic nervous system. The result of this effect on the I1-imidazoline receptors has been apparent in reduced activity in the sympathetic nerves. (demonstrated for cardiac, splanchnic and renal sympathetic nerves). Read about Moxonidine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PHYSIOTENS Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C02AC05	Moxonidine	C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AC Imidazoline receptor agonists
Discover more medicines within C02AC05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 9019Q, 9020R
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 06172328, 06172340, 06172363
Country: EE	Ravimiamet	Identifier(s): 1013779, 1013791
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 016642, 017806
Country: FR	Base de données publique des médicaments	Identifier(s): 60993898, 68782718
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 13750, 13769, 13776, 147143, 176195, 176198
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-577589830, HR-H-790867387
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003247, 1003249, 1011855, 1012537
Country: MT	Medicines Authority	Identifier(s): MA1507/01701, MA1507/01702, PI908/04701A, PI908/04702A
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100085105, 100085648, 100271285, 100271813, 100383015, 100384405, 100394958, 100404415, 100414508, 100414514, 100423460, 100435930, 100441280, 100451333
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68789001, W68789002, W68789003, W68790001, W68790002, W68790003
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5880096, 5880097
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699820090081, 8699820090104